ID   SYQ_HUMAN               Reviewed;         775 AA.
AC   P47897; B4DWJ2;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   10-MAY-2017, entry version 172.
DE   RecName: Full=Glutamine--tRNA ligase;
DE            EC=6.1.1.18;
DE   AltName: Full=Glutaminyl-tRNA synthetase;
DE            Short=GlnRS;
GN   Name=QARS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Liver;
RX   PubMed=8078941; DOI=10.1073/pnas.91.18.8670;
RA   Lamour V., Quevillon S., Diriong S., N'Guyen V.C., Lipinski M.,
RA   Mirande M.;
RT   "Evolution of the Glx-tRNA synthetase family: the glutaminyl enzyme as
RT   a case of horizontal gene transfer.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:8670-8674(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, Ovary, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-19; 206-225; 377-391 AND 602-616, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Hepatoma;
RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-309, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   RARS, VARIANTS MSCCA VAL-45; HIS-57; TRP-403 AND TRP-515, AND
RP   CHARACTERIZATION OF VARIANTS MSCCA VAL-45; HIS-57; TRP-403 AND
RP   TRP-515.
RX   PubMed=24656866; DOI=10.1016/j.ajhg.2014.03.003;
RA   Zhang X., Ling J., Barcia G., Jing L., Wu J., Barry B.J.,
RA   Mochida G.H., Hill R.S., Weimer J.M., Stein Q., Poduri A.,
RA   Partlow J.N., Ville D., Dulac O., Yu T.W., Lam A.T., Servattalab S.,
RA   Rodriguez J., Boddaert N., Munnich A., Colleaux L., Zon L.I., Soll D.,
RA   Walsh C.A., Nabbout R.;
RT   "Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause
RT   progressive microcephaly, cerebral-cerebellar atrophy, and intractable
RT   seizures.";
RL   Am. J. Hum. Genet. 94:547-558(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Plays a critical role in brain development.
CC       {ECO:0000269|PubMed:24656866}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-glutamine + tRNA(Gln) = AMP +
CC       diphosphate + L-glutaminyl-tRNA(Gln).
CC   -!- SUBUNIT: Part of a multisubunit complex that groups tRNA ligases
CC       for Arg, Asp, Glu, Gln, Ile, Leu, Lys, Met and Pro. Interacts with
CC       RARS. {ECO:0000269|PubMed:24656866}.
CC   -!- INTERACTION:
CC       P35609:ACTN2; NbExp=3; IntAct=EBI-347462, EBI-77797;
CC       Q08117:AES; NbExp=3; IntAct=EBI-347462, EBI-717810;
CC       Q86UW9:DTX2; NbExp=3; IntAct=EBI-10209725, EBI-740376;
CC       Q6P597:KLC3; NbExp=3; IntAct=EBI-10209725, EBI-1643885;
CC       Q9BRK4:LZTS2; NbExp=5; IntAct=EBI-347462, EBI-741037;
CC       Q9Y3C5:RNF11; NbExp=4; IntAct=EBI-347462, EBI-396669;
CC       Q99081:TCF12; NbExp=3; IntAct=EBI-347462, EBI-722877;
CC       Q9BUZ4:TRAF4; NbExp=5; IntAct=EBI-347462, EBI-3650647;
CC       Q15645:TRIP13; NbExp=5; IntAct=EBI-347462, EBI-358993;
CC       Q9H9H4:VPS37B; NbExp=3; IntAct=EBI-10209725, EBI-4400866;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24656866}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P47897-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P47897-2; Sequence=VSP_055107;
CC   -!- TISSUE SPECIFICITY: Highly expressed in fetal cerebral cortex,
CC       particularly in the ventricular zone, inner subventricular zone,
CC       outer subventricular zone, and cortical plate.
CC       {ECO:0000269|PubMed:24656866}.
CC   -!- DISEASE: Microcephaly, progressive, with seizures and cerebral and
CC       cerebellar atrophy (MSCCA) [MIM:615760]: A severe, autosomal
CC       recessive, neurodevelopmental and neurodegenerative disorder
CC       characterized by progressive microcephaly, severe seizures in
CC       infancy, atrophy of the cerebral cortex and cerebellar vermis, and
CC       mild atrophy of the cerebellar hemispheres, resulting in
CC       profoundly delayed development and hypotonia.
CC       {ECO:0000269|PubMed:24656866}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X76013; CAA53600.1; -; mRNA.
DR   EMBL; AK301559; BAG63054.1; -; mRNA.
DR   EMBL; AC135506; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000394; AAH00394.1; -; mRNA.
DR   EMBL; BC001567; AAH01567.1; -; mRNA.
DR   EMBL; BC029739; AAH29739.1; -; mRNA.
DR   CCDS; CCDS2788.1; -. [P47897-1]
DR   CCDS; CCDS63633.1; -. [P47897-2]
DR   PIR; I37422; I37422.
DR   RefSeq; NP_001259002.1; NM_001272073.1. [P47897-2]
DR   RefSeq; NP_005042.1; NM_005051.2. [P47897-1]
DR   UniGene; Hs.79322; -.
DR   PDB; 4R3Z; X-ray; 4.03 A; C=1-775.
DR   PDB; 4YE6; X-ray; 2.40 A; A=1-775.
DR   PDB; 4YE8; X-ray; 3.30 A; A=1-775.
DR   PDB; 4YE9; X-ray; 2.70 A; A=1-775.
DR   PDBsum; 4R3Z; -.
DR   PDBsum; 4YE6; -.
DR   PDBsum; 4YE8; -.
DR   PDBsum; 4YE9; -.
DR   ProteinModelPortal; P47897; -.
DR   SMR; P47897; -.
DR   BioGrid; 111797; 126.
DR   IntAct; P47897; 98.
DR   MINT; MINT-5004268; -.
DR   STRING; 9606.ENSP00000307567; -.
DR   BindingDB; P47897; -.
DR   ChEMBL; CHEMBL3054; -.
DR   DrugBank; DB00130; L-Glutamine.
DR   MoonProt; P47897; -.
DR   iPTMnet; P47897; -.
DR   PhosphoSitePlus; P47897; -.
DR   SwissPalm; P47897; -.
DR   DMDM; 1351170; -.
DR   EPD; P47897; -.
DR   MaxQB; P47897; -.
DR   PaxDb; P47897; -.
DR   PeptideAtlas; P47897; -.
DR   PRIDE; P47897; -.
DR   DNASU; 5859; -.
DR   Ensembl; ENST00000306125; ENSP00000307567; ENSG00000172053. [P47897-1]
DR   Ensembl; ENST00000414533; ENSP00000390015; ENSG00000172053. [P47897-2]
DR   GeneID; 5859; -.
DR   KEGG; hsa:5859; -.
DR   UCSC; uc003cvx.5; human. [P47897-1]
DR   CTD; 5859; -.
DR   DisGeNET; 5859; -.
DR   GeneCards; MIR6890; -.
DR   GeneCards; QARS; -.
DR   HGNC; HGNC:9751; QARS.
DR   HPA; HPA036986; -.
DR   HPA; HPA036987; -.
DR   MalaCards; MIR6890; -.
DR   MalaCards; QARS; -.
DR   MIM; 603727; gene.
DR   MIM; 615760; phenotype.
DR   neXtProt; NX_P47897; -.
DR   OpenTargets; ENSG00000172053; -.
DR   Orphanet; 404437; Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome.
DR   PharmGKB; PA34093; -.
DR   eggNOG; KOG1148; Eukaryota.
DR   eggNOG; COG0008; LUCA.
DR   GeneTree; ENSGT00550000074972; -.
DR   HOGENOM; HOG000259233; -.
DR   HOVERGEN; HBG000889; -.
DR   InParanoid; P47897; -.
DR   KO; K01886; -.
DR   OMA; FNAFKIL; -.
DR   OrthoDB; EOG091G026F; -.
DR   PhylomeDB; P47897; -.
DR   TreeFam; TF105683; -.
DR   Reactome; R-HSA-2408517; SeMet incorporation into proteins.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   ChiTaRS; QARS; human.
DR   GeneWiki; QARS; -.
DR   GenomeRNAi; 5859; -.
DR   PRO; PR:P47897; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000172053; -.
DR   CleanEx; HS_QARS; -.
DR   ExpressionAtlas; P47897; baseline and differential.
DR   Genevisible; P47897; HS.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IMP:CAFA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004819; F:glutamine-tRNA ligase activity; TAS:Reactome.
DR   GO; GO:0019901; F:protein kinase binding; IPI:CAFA.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; IMP:CAFA.
DR   GO; GO:0007420; P:brain development; IMP:UniProtKB.
DR   GO; GO:0006425; P:glutaminyl-tRNA aminoacylation; IDA:UniProtKB.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IDA:CAFA.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:CAFA.
DR   GO; GO:0032873; P:negative regulation of stress-activated MAPK cascade; IDA:CAFA.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:CAFA.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   Gene3D; 1.10.1160.10; -; 1.
DR   Gene3D; 2.40.240.10; -; 2.
DR   Gene3D; 3.40.50.620; -; 2.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR004514; Gln-tRNA-synth.
DR   InterPro; IPR007638; Gln-tRNA-synth_Ib_RNA-bd_2.
DR   InterPro; IPR007639; Gln-tRNA-synth_Ib_RNA-bd_N.
DR   InterPro; IPR000924; Glu/Gln-tRNA-synth.
DR   InterPro; IPR020061; Glu/Gln-tRNA-synth_Ib_a-bdl.
DR   InterPro; IPR020058; Glu/Gln-tRNA-synth_Ib_cat-dom.
DR   InterPro; IPR020059; Glu/Gln-tRNA-synth_Ib_codon-bd.
DR   InterPro; IPR020056; Rbsml_L25/Gln-tRNA_synth_b-brl.
DR   InterPro; IPR011035; Ribosomal_L25/Gln-tRNA_synth.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00749; tRNA-synt_1c; 1.
DR   Pfam; PF03950; tRNA-synt_1c_C; 1.
DR   Pfam; PF04558; tRNA_synt_1c_R1; 1.
DR   Pfam; PF04557; tRNA_synt_1c_R2; 1.
DR   PRINTS; PR00987; TRNASYNTHGLU.
DR   SUPFAM; SSF50715; SSF50715; 1.
DR   TIGRFAMs; TIGR00440; glnS; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Epilepsy; Ligase;
KW   Nucleotide-binding; Phosphoprotein; Primary microcephaly;
KW   Protein biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2    775       Glutamine--tRNA ligase.
FT                                /FTId=PRO_0000195860.
FT   MOTIF       270    280       "HIGH" region.
FT   MOTIF       493    497       "KMSKS" region.
FT   BINDING     496    496       ATP. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   MOD_RES      70     70       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     309    309       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     495    495       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      78     89       SKKIHTEPQLSA -> T (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055107.
FT   VARIANT      45     45       G -> V (in MSCCA; results in reduced
FT                                glutaminyl-tRNA aminoacylation activity;
FT                                does not affect interaction with RARS;
FT                                dbSNP:rs587777331).
FT                                {ECO:0000269|PubMed:24656866}.
FT                                /FTId=VAR_071189.
FT   VARIANT      57     57       Y -> H (in MSCCA; results in reduced
FT                                glutaminyl-tRNA aminoacylation activity;
FT                                does not affect interaction with RARS;
FT                                dbSNP:rs587777333).
FT                                {ECO:0000269|PubMed:24656866}.
FT                                /FTId=VAR_071190.
FT   VARIANT     403    403       R -> W (in MSCCA; results in loss of
FT                                glutaminyl-tRNA aminoacylation activity;
FT                                does not interact with RARS; results in
FT                                reduced protein solubility;
FT                                dbSNP:rs587777332).
FT                                {ECO:0000269|PubMed:24656866}.
FT                                /FTId=VAR_071191.
FT   VARIANT     515    515       R -> W (in MSCCA; results in loss of
FT                                glutaminyl-tRNA aminoacylation activity;
FT                                results in reduced protein solubility;
FT                                dbSNP:rs587777334).
FT                                {ECO:0000269|PubMed:24656866}.
FT                                /FTId=VAR_071192.
FT   HELIX         6     12       {ECO:0000244|PDB:4YE6}.
FT   HELIX        17     25       {ECO:0000244|PDB:4YE6}.
FT   HELIX        27     42       {ECO:0000244|PDB:4YE6}.
FT   TURN         43     45       {ECO:0000244|PDB:4YE6}.
FT   HELIX        50     62       {ECO:0000244|PDB:4YE6}.
FT   HELIX        66     68       {ECO:0000244|PDB:4YE6}.
FT   HELIX        69     77       {ECO:0000244|PDB:4YE6}.
FT   HELIX        84     94       {ECO:0000244|PDB:4YE6}.
FT   HELIX       104    110       {ECO:0000244|PDB:4YE6}.
FT   HELIX       119    140       {ECO:0000244|PDB:4YE6}.
FT   HELIX       141    143       {ECO:0000244|PDB:4YE6}.
FT   HELIX       147    154       {ECO:0000244|PDB:4YE6}.
FT   HELIX       162    177       {ECO:0000244|PDB:4YE6}.
FT   HELIX       220    223       {ECO:0000244|PDB:4YE6}.
FT   HELIX       226    229       {ECO:0000244|PDB:4YE6}.
FT   HELIX       237    239       {ECO:0000244|PDB:4YE6}.
FT   HELIX       249    260       {ECO:0000244|PDB:4YE6}.
FT   STRAND      265    268       {ECO:0000244|PDB:4YE6}.
FT   HELIX       278    293       {ECO:0000244|PDB:4YE6}.
FT   STRAND      297    302       {ECO:0000244|PDB:4YE6}.
FT   HELIX       312    324       {ECO:0000244|PDB:4YE6}.
FT   STRAND      330    334       {ECO:0000244|PDB:4YE6}.
FT   HELIX       335    338       {ECO:0000244|PDB:4YE6}.
FT   HELIX       339    351       {ECO:0000244|PDB:4YE6}.
FT   STRAND      354    358       {ECO:0000244|PDB:4YE6}.
FT   TURN        374    377       {ECO:0000244|PDB:4YE6}.
FT   HELIX       380    391       {ECO:0000244|PDB:4YE6}.
FT   STRAND      401    404       {ECO:0000244|PDB:4YE6}.
FT   STRAND      416    420       {ECO:0000244|PDB:4YE6}.
FT   TURN        426    428       {ECO:0000244|PDB:4YE6}.
FT   STRAND      433    436       {ECO:0000244|PDB:4YE6}.
FT   HELIX       438    448       {ECO:0000244|PDB:4YE6}.
FT   STRAND      452    457       {ECO:0000244|PDB:4YE6}.
FT   HELIX       464    473       {ECO:0000244|PDB:4YE6}.
FT   STRAND      480    484       {ECO:0000244|PDB:4YE6}.
FT   STRAND      487    489       {ECO:0000244|PDB:4YE6}.
FT   HELIX       496    504       {ECO:0000244|PDB:4YE6}.
FT   STRAND      507    510       {ECO:0000244|PDB:4YE6}.
FT   HELIX       519    524       {ECO:0000244|PDB:4YE6}.
FT   HELIX       529    539       {ECO:0000244|PDB:4YE6}.
FT   STRAND      546    548       {ECO:0000244|PDB:4YE6}.
FT   HELIX       551    564       {ECO:0000244|PDB:4YE6}.
FT   STRAND      570    576       {ECO:0000244|PDB:4YE6}.
FT   STRAND      578    581       {ECO:0000244|PDB:4YE6}.
FT   STRAND      592    594       {ECO:0000244|PDB:4YE6}.
FT   HELIX       599    601       {ECO:0000244|PDB:4YE6}.
FT   STRAND      603    606       {ECO:0000244|PDB:4YE9}.
FT   STRAND      613    615       {ECO:0000244|PDB:4YE6}.
FT   TURN        616    618       {ECO:0000244|PDB:4YE6}.
FT   STRAND      647    650       {ECO:0000244|PDB:4YE6}.
FT   STRAND      654    656       {ECO:0000244|PDB:4YE6}.
FT   STRAND      661    663       {ECO:0000244|PDB:4YE6}.
FT   STRAND      681    683       {ECO:0000244|PDB:4YE6}.
FT   STRAND      685    692       {ECO:0000244|PDB:4YE6}.
FT   STRAND      695    700       {ECO:0000244|PDB:4YE6}.
FT   TURN        702    705       {ECO:0000244|PDB:4YE6}.
FT   TURN        711    714       {ECO:0000244|PDB:4YE6}.
FT   STRAND      720    722       {ECO:0000244|PDB:4YE6}.
FT   STRAND      725    728       {ECO:0000244|PDB:4YE6}.
FT   STRAND      732    734       {ECO:0000244|PDB:4YE6}.
FT   STRAND      740    743       {ECO:0000244|PDB:4YE6}.
FT   TURN        744    746       {ECO:0000244|PDB:4YE6}.
FT   STRAND      747    751       {ECO:0000244|PDB:4YE6}.
FT   STRAND      757    759       {ECO:0000244|PDB:4YE6}.
FT   STRAND      761    766       {ECO:0000244|PDB:4YE6}.
SQ   SEQUENCE   775 AA;  87799 MW;  ADDE23E6C442FF73 CRC64;
     MAALDSLSLF TSLGLSEQKA RETLKNSALS AQLREAATQA QQTLGSTIDK ATGILLYGLA
     SRLRDTRRLS FLVSYIASKK IHTEPQLSAA LEYVRSHPLD PIDTVDFERE CGVGVIVTPE
     QIEEAVEAAI NRHRPQLLVE RYHFNMGLLM GEARAVLKWA DGKMIKNEVD MQVLHLLGPK
     LEADLEKKFK VAKARLEETD RRTAKDVVEN GETADQTLSL MEQLRGEALK FHKPGENYKT
     PGYVVTPHTM NLLKQHLEIT GGQVRTRFPP EPNGILHIGH AKAINFNFGY AKANNGICFL
     RFDDTNPEKE EAKFFTAICD MVAWLGYTPY KVTYASDYFD QLYAWAVELI RRGLAYVCHQ
     RGEELKGHNT LPSPWRDRPM EESLLLFEAM RKGKFSEGEA TLRMKLVMED GKMDPVAYRV
     KYTPHHRTGD KWCIYPTYDY THCLCDSIEH ITHSLCTKEF QARRSSYFWL CNALDVYCPV
     QWEYGRLNLH YAVVSKRKIL QLVATGAVRD WDDPRLFTLT ALRRRGFPPE AINNFCARVG
     VTVAQTTMEP HLLEACVRDV LNDTAPRAMA VLESLRVIIT NFPAAKSLDI QVPNFPADET
     KGFHQVPFAP IVFIERTDFK EEPEPGFKRL AWGQPVGLRH TGYVIELQHV VKGPSGCVES
     LEVTCRRADA GEKPKAFIHW VSQPLMCEVR LYERLFQHKN PEDPTEVPGG FLSDLNLASL
     HVVDAALVDC SVALAKPFDK FQFERLGYFS VDPDSHQGKL VFNRTVTLKE DPGKV
//
